pharmaphorum12y
GSK’s influenza vaccine is approved for use in the US
GSK’s influenza vaccine, Fluarix Quadrivalent, has been approved by the US FDA for the immunisation of adults and children aged three years and older to help prevent disease caused by seasonal ...
‘Adequate supply’ of flu vaccine, more stock coming
The shortage of certain types of influenza vaccines could end as early as next month with the arrival of new stock, says ...
Some flu shots out of stock but don’t panic, says Malaysia’s health minister
Malaysia’s health ministry said there is no rising trend of influenza cases in Malaysia. Read more at straitstimes.com.
Zacks.com on MSN6d
GSK Beats on Q4 Earnings & Sales, Stock Up on Raised Long-Term Outlook
GSK plc GSK reported fourth-quarter 2024 core earnings of 59 cents per American depositary share (ADS), which beat the Zacks ...
The Star3d
Some flu shots out of stock, but don't panic, says Dzulkefly
“Fluarix Tetra (GSK) is no longer marketed, and SKYCellflu (Pharmaniaga Marketing, SK Bioscience Korea) has no stock in the country. “Currently, there is an unexpected surge in demand for ...
pharmaphorum1y
Moderna eyes 2025 approval for COVID, flu combination jab
The mRNA-1083 generated an equivalent or better immunological response compared to current flu vaccines, matching GSK’s Fluarix Quadrivalent in adults aged 50 to 64 and outperforming Sanofi’s ...
Hosted on MSN1y
GSK Lags Q4 Earnings, Tops Sales, Issues Upbeat '24 Guidance
GSK plc GSK reported adjusted earnings of 72 ... Sales of the influenza vaccine, Fluarix, were down 64% at CER. Sales of Established vaccines were up 8% year over year. Adjusted selling, general ...